Fibroblast phenotypes and their relevance for wound healing

International Journal of Lower Extremity Wounds

Volumn 4, Issue 1, 2005, Pages 9-11

  Middelkoop, Esther ^a,b  

^a ASSOCIATION OF DUTCH BURN CENTRES   (Netherlands)

^b Dutch Burns Foundation   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROLIFERATION; CYTOSKELETON; EDITORIAL; FIBROBLAST; MYOFIBROBLAST; PHENOTYPE; PRIORITY JOURNAL; SKIN FIBROBLAST; WOUND HEALING; CLASSIFICATION; HUMAN; PHYSIOLOGY;

FIBROBLASTS; HUMANS; PHENOTYPE; WOUND HEALING;

EID: 20644443095     PISSN: 15347346     EISSN: None     Source Type: Journal    
DOI: 10.1177/1534734605275174     Document Type: Editorial

References (11)

1. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003;200(4):500-3.
2. van den Bogaerdt AJ, van Zuijlen PPM, van Galen M, Lamme EN, Middelkoop E. The suitability of cells from different tissues to be used in tissue engineered skin substitutes. Arch Dermatol Res 2002;294(3):135-42.
3. Stephens P, Davies KJ, Occleston N, et al. Skin and oral fibroblasts exhibit phenotypic differences in extracellular matrix organization and matrix metalloproteinase activity. Br J Dermatol 2001;144(2):229-37.
4. Chin GS, Kim WJ, Lee TY, et al. Differential expression of receptor tyrosine kinases and Shc in fetal and adult rat fibroblasts: toward defining scarless versus scarring fibroblast phenotypes. Plast Reconstr Surg 2000;105:972-9.
5. Chipev CC, Simon M. Phenotypic differences between dermal fibroblasts from different body sites determine their responses to tension and TGF beta1. BMC Dermatol 2002;2(1):13.
6. Leask A. Transcriptional profiling of the scleroderma fibroblast reveals a potential for connective tissue growth factor (CTGF) in pathological fibrosis. Keio J Med 2004;53(2):74-7.
7. Loots MA, Lamme EN, Mekkes JR, Bos JD, Middelkoop E. Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation. Arch Dermatol Res 1999;291:93-9.
8. Nakamura N, Iijima T, Mase K, et al. Phenotypic differences of proliferating fibroblasts in the stroma of lung adenocarcinoma and normal bronchus tissue. Cancer Sci 2004;95(3):226-32.
9. Hehenberger K, Heilborn JD, Brismar K, Hansson A. Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of 1-lactate. Wound Repair Regen 1998;6(2):135-41.
10. Loot MA, Kenter SB, Au FL, et al. Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-I, bFGF and PDGF-AB compared to controls. Eur J Cell Biol 2002;81(3):153-60.
11. Margolis DJ. The swings and roundabouts of randomized controlled studies in wound healing. Int J Lower Extremity Wounds 2004;3(1):4-6.